146 related articles for article (PubMed ID: 18273902)
21. A fatty acid analogue targeting mitochondria exerts a plasma triacylglycerol lowering effect in rats with impaired carnitine biosynthesis.
Lindquist C; Bjørndal B; Rossmann CR; Svardal A; Hallström S; Berge RK
PLoS One; 2018; 13(3):e0194978. PubMed ID: 29590220
[TBL] [Abstract][Full Text] [Related]
22. Mildronate decreases carnitine availability and up-regulates glucose uptake and related gene expression in the mouse heart.
Liepinsh E; Vilskersts R; Skapare E; Svalbe B; Kuka J; Cirule H; Pugovics O; Kalvinsh I; Dambrova M
Life Sci; 2008 Oct; 83(17-18):613-9. PubMed ID: 18801379
[TBL] [Abstract][Full Text] [Related]
23. Effects of long-term mildronate treatment on cardiac and liver functions in rats.
Liepinsh E; Kuka J; Svalbe B; Vilskersts R; Skapare E; Cirule H; Pugovics O; Kalvinsh I; Dambrova M
Basic Clin Pharmacol Toxicol; 2009 Dec; 105(6):387-94. PubMed ID: 19663820
[TBL] [Abstract][Full Text] [Related]
24. Effects of heavy metal cations on the mitochondrial ornithine/citrulline transporter reconstituted in liposomes.
Tonazzi A; Indiveri C
Biometals; 2011 Dec; 24(6):1205-15. PubMed ID: 21769608
[TBL] [Abstract][Full Text] [Related]
25. Mitochondria as the target for mildronate's protective effects in azidothymidine (AZT)-induced toxicity of isolated rat liver mitochondria.
Pupure J; Fernandes MA; Santos MS; Moreno AJ; Kalvinsh I; Klusa V; Oliveira CR
Cell Biochem Funct; 2008; 26(5):620-31. PubMed ID: 18508390
[TBL] [Abstract][Full Text] [Related]
26. Site-directed mutagenesis of charged amino acids of the human mitochondrial carnitine/acylcarnitine carrier: insight into the molecular mechanism of transport.
Giangregorio N; Tonazzi A; Console L; Indiveri C; Palmieri F
Biochim Biophys Acta; 2010; 1797(6-7):839-45. PubMed ID: 20347717
[TBL] [Abstract][Full Text] [Related]
27. Mildronate, a regulator of energy metabolism, reduces atherosclerosis in apoE/LDLR-/- mice.
Vilskersts R; Liepinsh E; Mateuszuk L; Grinberga S; Kalvinsh I; Chlopicki S; Dambrova M
Pharmacology; 2009; 83(5):287-93. PubMed ID: 19325254
[TBL] [Abstract][Full Text] [Related]
28. [The effect of mildronate on carnitine-dependent and carnitine-independent ketogenesis in rats].
Simkhovich BZ; Meĭrena DV; Khagi KhB; Shutenko ZhV; Molodchina TN; Kalvin'sh IIa; Lukevits EIa
Farmakol Toksikol; 1991; 54(4):41-2. PubMed ID: 1786824
[TBL] [Abstract][Full Text] [Related]
29. [Change of concentration of L-carnitine in blood and other tissues in rats on a background of the alcohol intake and influence of mildronate on its level].
Sakvarelidze EP
Georgian Med News; 2006 Aug; (137):94-6. PubMed ID: 16980758
[TBL] [Abstract][Full Text] [Related]
30. Mildronate: cardioprotective action through carnitine-lowering effect.
Dambrova M; Liepinsh E; Kalvinsh I
Trends Cardiovasc Med; 2002 Aug; 12(6):275-9. PubMed ID: 12242052
[TBL] [Abstract][Full Text] [Related]
31. Kinetic characterization of the reconstituted carnitine carrier from rat liver mitochondria.
Indiveri C; Tonazzi A; Prezioso G; Palmieri F
Biochim Biophys Acta; 1991 Jun; 1065(2):231-8. PubMed ID: 2059655
[TBL] [Abstract][Full Text] [Related]
32. Protective effects of mildronate in an experimental model of type 2 diabetes in Goto-Kakizaki rats.
Liepinsh E; Vilskersts R; Zvejniece L; Svalbe B; Skapare E; Kuka J; Cirule H; Grinberga S; Kalvinsh I; Dambrova M
Br J Pharmacol; 2009 Aug; 157(8):1549-56. PubMed ID: 19594753
[TBL] [Abstract][Full Text] [Related]
33. Mitochondrial carnitine/acylcarnitine transporter, a novel target of mercury toxicity.
Tonazzi A; Giangregorio N; Console L; Scalise M; La Russa D; Notaristefano C; Brunelli E; Barca D; Indiveri C
Chem Res Toxicol; 2015 May; 28(5):1015-22. PubMed ID: 25849418
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of the OCTN2 carnitine transporter by HgCl2 and methylmercury in the proteoliposome experimental model: insights in the mechanism of toxicity.
Pochini L; Peta V; Indiveri C
Toxicol Mech Methods; 2013 Feb; 23(2):68-76. PubMed ID: 22900493
[TBL] [Abstract][Full Text] [Related]
35. [The effect of mildronate on disorders of the cardiac contractile function in rats caused by an excess of free fatty acids and ischemia].
Simkhovich BZ; Briede IaL; Ozola RA; Meĭrena DV; Kalvin'sh IIa; Lukevits EIa
Farmakol Toksikol; 1990; 53(5):27-9. PubMed ID: 2253743
[TBL] [Abstract][Full Text] [Related]
36. Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma-butyrobetaine contents and cardioprotection in isolated rat heart infarction.
Liepinsh E; Vilskersts R; Loca D; Kirjanova O; Pugovichs O; Kalvinsh I; Dambrova M
J Cardiovasc Pharmacol; 2006 Dec; 48(6):314-9. PubMed ID: 17204911
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of mitochondrial carnitine/acylcarnitine transporter by H(2)O(2): molecular mechanism and possible implication in pathophysiology.
Tonazzi A; Console L; Indiveri C
Chem Biol Interact; 2013 Apr; 203(2):423-9. PubMed ID: 23402788
[TBL] [Abstract][Full Text] [Related]
38. Carnitine congener mildronate protects against stress- and haloperidol-induced impairment in memory and brain protein expression in rats.
Beitnere U; Dzirkale Z; Isajevs S; Rumaks J; Svirskis S; Klusa V
Eur J Pharmacol; 2014 Dec; 745():76-83. PubMed ID: 25446926
[TBL] [Abstract][Full Text] [Related]
39. Identification by site-directed mutagenesis of a hydrophobic binding site of the mitochondrial carnitine/acylcarnitine carrier involved in the interaction with acyl groups.
Tonazzi A; Console L; Giangregorio N; Indiveri C; Palmieri F
Biochim Biophys Acta; 2012 May; 1817(5):697-704. PubMed ID: 22365929
[TBL] [Abstract][Full Text] [Related]
40. Bacterial overexpression, purification, and reconstitution of the carnitine/acylcarnitine carrier from rat liver mitochondria.
Indiveri C; Iacobazzi V; Giangregorio N; Palmieri F
Biochem Biophys Res Commun; 1998 Aug; 249(3):589-94. PubMed ID: 9731180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
